http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100537153-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6897 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-02 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-49 |
| filingDate | 1997-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100537153-B1 |
| titleOfInvention | Methods and compositions for determining antiviral drug susceptibility and resistance and screening of antiviral drugs |
| abstract | The present invention provides a new test method for measuring susceptibility to antiviral drugs, the test method comprising the steps of (a) introducing into a host cell a resistance test vector comprising segments and indicator genes derived from the patient; ; (b) culturing the host cell of step (a); (c) measuring the expression of the indicator gene in the target host cell; (d) comparing the expression of the indicator gene measured by performing steps (a)-(c) and the expression of the indicator gene of step (c) in the absence of an antiviral drug, wherein Test concentration of the viral drug is the steps (a)-(c); Present in steps (b)-(c) or (c). The present invention also provides a method for measuring the resistance of an antiviral drug in a patient. The invention also provides a method for assessing the biological effect of a compound of a candidate antiviral drug. A resistance test vector comprising a segment derived from a patient and an indicator gene and a composition comprising a host cell transformed with the resistance test vector are provided. |
| priorityDate | 1996-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 760.